Sign in
4/A

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-033419

Chief Financial Officer sold 2,012 shares at $11.16 ($22,454)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2023-04-28 Sale −2,012 $11.16 $22,454 148,123 D
Open-market sales · 2,012 sh · avg $11.16 · $22,454
Loading xslF345X04/doc4a.xml…